FDA Receives Repros Therapeutics Inc. (RPRX)' Submission for Special Protocol Assessment Documentation for Pivotal Studies for Androxal(R)
More...
|
Ambit Biosciences and Teva Pharmaceutical Industries Limited (TEVA) Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
More...
|
Optimer Pharmaceuticals, Inc. (OPTR) Updates on DIFICID Treatment on CDAD Patients
More...
|
NovaBay Pharmaceuticals, Inc. Enrolls First Patients in Global BAYnovation(TM) Phase 2b Study for Adenoviral Conjunctivitis
More...
|
Avraham Pharmaceuticals Ltd. Announces Commencement of a Phase 2 Study of Ladostigil for the Treatment of MCI
More...
|
Sigmoid Pharma Completes Phase II Trial of CyCol™ in More than 100 Ulcerative Colitis Patients and Raises €3 Million
More...
|
Medgenics, Inc. Receives FDA Clearance to Commence Phase IIb Trial of EPODURE for Sustained Anemia Treatment in Dialysis Patients
More...
|
Amgen (AMGN)'s BiTE(R) Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
More...
|
Spectrum Pharmaceuticals, Inc. (SPPI) Commences Phase 2 Study of ZEVALIN® in Combination With the Redox Modulating Agent Motexafin Gadolinium (MGd)
More...
|
StemCells Inc. (STEM) Reports Positive Interim Safety Data From Spinal Cord Injury Trial
More...
|
Clinical Data Published for a Phase I AADC-deficiency Trial Using a Gene Therapy Manufactured by Florida Biologix
More...
|
Cannabis Science Inc. Receives New Photos and Information on Patient Three's Previous Examinations and the Current Progress on his Severe Squamous Cell Carcinoma
More...
|
Ceregene, Inc. Parkinson's Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
More...
|
CytoDyn Announces Plans to Move Forward With Next Stage of Research of CytoFeline™
More...
|
Neuren Pharmaceuticals Limited Holds Pre-IND Meeting on Proposed Rett Syndrome Clinical Trials With FDA
More...
|
Genetic Immunity Clinical Trial Data Published in PLoS ONE
More...
|
Sagent Pharmaceuticals, Inc. Announces Launch of Irinotecan Hydrochloride Injection in Single Dose Vials
More...
|